Hints and tips:
Related Special Reports
...Many sectors argue that such a blanket ban is too broad, with many variants critical to green technologies, pharmaceuticals and chipmaking....
...He co-led at trial against 3M, which faced mass tort action on behalf of more than 250,000 veterans....
...The pharmaceutical industry and governments are failing to invest enough in replacing antibiotics with newer drugs that bacteria aren’t resistant to....
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
...Judges have pushed back on “mass tort” bankruptcies involving 3M and Purdue Pharma....
...And on closer look, those block trades weren’t quite as war-profiteering as they might sound: These are trades in SolarEdge Technologies and Teva Pharmaceuticals....
...But they warn that the ruling casts a shadow over the company as it seeks to remodel itself as an innovator in the pharmaceutical and medical devices sectors....
...Post-it maker 3M, oilfield services company Halliburton, railroad operator Union Pacific and homebuilder DR Horton are also due to publish results....
...But Roundup, along with 3M’s potential multi-billion-dollar legal exposure to faulty earplugs, had been the “tape bombs” that changed investor psychology, he said....
...We also talked about 3M now emboldened by the apparent success of J&J’s LTL unit last year. A 3M subsidiary applied for bankruptcy. But essentially this didn’t work out the way 3M wanted....
...The company now expects to deliver 1.3m doses to the EU's 27 member states, plus Iceland and Norway, down from the 2.6m forecast for this week that it made in mid-March, according to documents seen by the...
...Update: A new version of this episode was uploaded on June 21, 2022 to update the number and outcome of trials 3M has faced related to one of its products....
...The government has also pre-ordered 3m courses of Merck’s antiviral pill, which is still going through the FDA approval process....
...Though South African scientists raised the alarm on Omicron, more than 80 per cent of the 6.3m genomes uploaded to Gisaid come from North America and Europe....
...Roche said it would use debt to fund its repurchase of the 53.3m bearer shares that Novartis holds....
...About 2.3m doses have been administered to date, the WHO said. The shot is a recombinant-protein based vaccine, a technology harnessed in vaccines used against other diseases....
...The contrast, Chinese health officials and experts said, reflected how Beijing’s unwavering zero-Covid policy had proven a “magic bullet”, preventing at least 200m infections and 3m deaths....
...More than 3m Americans aged over-65 are yet to receive their first jab, including almost one in 10 of those aged over 75....
...In the first six months of this year, CureVac is recognising €29.3m of revenues from its two programmes with GSK. The company does not yet have an approved product to sell....
...He also warned it would take months for pharmaceutical companies to manufacture new variant-specific vaccines at scale....
...An average of 5.9m doses were administered a day, compared to 4.3m a day in July....
...AstraZeneca has admitted that the launch of Covid-19 vaccine production at Siam Bioscience, the Thai pharmaceutical company owned by the billionaire King Maha Vajiralongkorn, had been “complicated”, but...
...Real estate groups have also done well: Foxtons swung to a £3.3m pre-tax profit thanks to booming demand for homes in the UK....
...Here’s the FT’s US pharmaceuticals correspondent Jamie Smyth. Jamie SmythA woman named Jacqueline Fox files a personal injury lawsuit against J&J....
...The global health body was upbeat about the pharmaceutical response to emerging variants....
International Edition